Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Genetic Predictors of Lithium Response in Bipolar Disorder
Genetic Studies of Psychiatric Illness
Status: Enrolling
Updated:  7/26/2016
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Genetic Predictors of Lithium Response in Bipolar Disorder
Genetic Studies of Psychiatric Illness
Status: Enrolling
Updated: 7/26/2016
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine
A Single Dose Pharmacokinetic Study of Topical and Rectal Quetiapine Compared to Oral Quetiapine in Healthy Adults
Status: Enrolling
Updated:  7/26/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine
A Single Dose Pharmacokinetic Study of Topical and Rectal Quetiapine Compared to Oral Quetiapine in Healthy Adults
Status: Enrolling
Updated: 7/26/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
Status: Enrolling
Updated:  7/26/2016
Center For Social Innovation
mi
from
Needham, MA
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
Status: Enrolling
Updated: 7/26/2016
Center For Social Innovation
mi
from
Needham, MA
Click here to add this to my saved trials
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
Status: Enrolling
Updated:  7/26/2016
New York State Psychiatric Institute
mi
from
New York, NY
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant
Status: Enrolling
Updated: 7/26/2016
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Neurobehavioral Model of HIV in Injection Drug Users
Neurobehavioral Model of HIV in Injection Drug Users
Status: Enrolling
Updated:  8/1/2016
University of Florida
mi
from
Baltimore, MD
Neurobehavioral Model of HIV in Injection Drug Users
Neurobehavioral Model of HIV in Injection Drug Users
Status: Enrolling
Updated: 8/1/2016
University of Florida
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Los Ageles, CA
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Los Ageles, CA
Click here to add this to my saved trials
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New Haven, CT
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Bronx, NY
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over, Exploratory Biomarker and Safety and Tolerability Study of a Single Dose of RO5028442 in Adult Male High-functioning Autistic Patients
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Los Ageles, CA
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Los Ageles, CA
Click here to add this to my saved trials
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New Haven, CT
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Using The HOPES Program in Transition Care
Status: Enrolling
Updated:  8/1/2016
Glencliff Home
mi
from
Glencliff, NH
Using The HOPES Program in Transition Care
Status: Enrolling
Updated: 8/1/2016
Glencliff Home
mi
from
Glencliff, NH
Click here to add this to my saved trials
Emergency Physician Brief Interventions for Alcohol
Emergency Physician Brief Interventions for Alcohol
Status: Enrolling
Updated:  8/4/2016
Yale University
mi
from
New Haven, CT
Emergency Physician Brief Interventions for Alcohol
Emergency Physician Brief Interventions for Alcohol
Status: Enrolling
Updated: 8/4/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Computerized Anxiety Treatment for Suicide
Suicide Risk Prevention Among Patients With Anxiety Psychopathology
Status: Enrolling
Updated:  8/8/2016
Anxiety and Behavioral Health Clinic
mi
from
Tallahassee, FL
Computerized Anxiety Treatment for Suicide
Suicide Risk Prevention Among Patients With Anxiety Psychopathology
Status: Enrolling
Updated: 8/8/2016
Anxiety and Behavioral Health Clinic
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
South Bay Treatment Center
mi
from
San Diego, CA
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
South Bay Treatment Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
Matrix Institute on Addictions
mi
from
Tarzana, CA
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
Matrix Institute on Addictions
mi
from
Tarzana, CA
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
Torrance Site
mi
from
Torrance, CA
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
Torrance Site
mi
from
Torrance, CA
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
University of Colorado Health Sciences Center
mi
from
Denver, CO
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
University of Colorado Health Sciences Center
mi
from
Denver, CO
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
John A. Burns School of Medicine
mi
from
Honolulu, HI
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
John A. Burns School of Medicine
mi
from
Honolulu, HI
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
Powell Chemical Dependency Center
mi
from
Des Moines, IA
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
Powell Chemical Dependency Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
START Research and Treatment
mi
from
Kansas City, MO
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
START Research and Treatment
mi
from
Kansas City, MO
Click here to add this to my saved trials
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated:  8/9/2016
Salt Lake City V.A. Medical Center
mi
from
Salt Lake City, UT
Ph2 Modafinil Meth - 1
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Status: Enrolling
Updated: 8/9/2016
Salt Lake City V.A. Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Addiction Housing Case Management for Homeless Veterans
Addiction Housing Case Management for Homeless Veterans Enrolled in Addictions Treatment
Status: Enrolling
Updated:  8/9/2016
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Addiction Housing Case Management for Homeless Veterans
Addiction Housing Case Management for Homeless Veterans Enrolled in Addictions Treatment
Status: Enrolling
Updated: 8/9/2016
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
HIV, Buprenorphine, and the Criminal Justice System
HIV, Buprenorphine, and the Criminal Justice System
Status: Enrolling
Updated:  8/10/2016
Howard University
mi
from
Washington,
HIV, Buprenorphine, and the Criminal Justice System
HIV, Buprenorphine, and the Criminal Justice System
Status: Enrolling
Updated: 8/10/2016
Howard University
mi
from
Washington,
Click here to add this to my saved trials
Gulf War 1 Veteran Healthcare Satisfaction
Gulf War 1 Veteran Patient Satisfaction With VA Primary Care: A Survey Study.
Status: Enrolling
Updated:  8/10/2016
University of Utah
mi
from
Salt Lake City, UT
Gulf War 1 Veteran Healthcare Satisfaction
Gulf War 1 Veteran Patient Satisfaction With VA Primary Care: A Survey Study.
Status: Enrolling
Updated: 8/10/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Gulf War 1 Veteran Healthcare Satisfaction
Gulf War 1 Veteran Patient Satisfaction With VA Primary Care: A Survey Study.
Status: Enrolling
Updated:  8/10/2016
VA SLC Health Care System
mi
from
Salt Lake City, UT
Gulf War 1 Veteran Healthcare Satisfaction
Gulf War 1 Veteran Patient Satisfaction With VA Primary Care: A Survey Study.
Status: Enrolling
Updated: 8/10/2016
VA SLC Health Care System
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
An Intervention to Reduce Delirium After Cardiac Surgery
An Intervention to Reduce Delirium After Cardiac Surgery
Status: Enrolling
Updated:  8/10/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
An Intervention to Reduce Delirium After Cardiac Surgery
An Intervention to Reduce Delirium After Cardiac Surgery
Status: Enrolling
Updated: 8/10/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder
Examining Written Disclosure as an Intervention for Posttraumatic Stress Disorder
Status: Enrolling
Updated:  8/11/2016
VA Boston Healthcare System, National Center for PTSD
mi
from
Boston, MA
Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder
Examining Written Disclosure as an Intervention for Posttraumatic Stress Disorder
Status: Enrolling
Updated: 8/11/2016
VA Boston Healthcare System, National Center for PTSD
mi
from
Boston, MA
Click here to add this to my saved trials
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Status: Enrolling
Updated:  8/12/2016
Connecticut Mental Health Center
mi
from
New Haven, CT
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Status: Enrolling
Updated: 8/12/2016
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft
Status: Enrolling
Updated:  8/15/2016
Sunset Dialysis Center
mi
from
Rancho Cordova, CA
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft
Status: Enrolling
Updated: 8/15/2016
Sunset Dialysis Center
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft
Status: Enrolling
Updated:  8/15/2016
Natomas Dialysis
mi
from
Sacramento, CA
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft
Status: Enrolling
Updated: 8/15/2016
Natomas Dialysis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft
Status: Enrolling
Updated:  8/15/2016
Asheville Kidney Center
mi
from
Asheville, NC
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
A Randomized Controlled Study of the Effect of a Needle Phobia or Apprehension Intervention With or Without Synera® on Conversion From Central Venous Catheters to Arteriovenous Fistula or Graft
Status: Enrolling
Updated: 8/15/2016
Asheville Kidney Center
mi
from
Asheville, NC
Click here to add this to my saved trials
Cranial Electrotherapy Stimulation (CES) Therapy
Cranial Electrotherapy Stimulation (CES) Therapy for PTSD and Anxiety in OEF/OIF Veterans With Mild TBI
Status: Enrolling
Updated:  8/18/2016
Audie L. Murphy VA Hospital
mi
from
San Antonio, TX
Cranial Electrotherapy Stimulation (CES) Therapy
Cranial Electrotherapy Stimulation (CES) Therapy for PTSD and Anxiety in OEF/OIF Veterans With Mild TBI
Status: Enrolling
Updated: 8/18/2016
Audie L. Murphy VA Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated:  8/23/2016
The Medical Research Network, LLC
mi
from
New York, NY
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated: 8/23/2016
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
Patient-Centered Trauma Treatment
Patient-Centered Trauma Treatment for PTSD and Substance Abuse: Is it an Effective Treatment Option?
Status: Enrolling
Updated:  9/8/2016
Inside Out
mi
from
Espanola, NM
Patient-Centered Trauma Treatment
Patient-Centered Trauma Treatment for PTSD and Substance Abuse: Is it an Effective Treatment Option?
Status: Enrolling
Updated: 9/8/2016
Inside Out
mi
from
Espanola, NM
Click here to add this to my saved trials
Parent Program to Improve Child Behavior Problems
Improving Child Behavior Problems in the Primary Care Setting
Status: Enrolling
Updated:  9/19/2016
CHOP Primary Care, South Philadelphia
mi
from
Philadelphia, PA
Parent Program to Improve Child Behavior Problems
Improving Child Behavior Problems in the Primary Care Setting
Status: Enrolling
Updated: 9/19/2016
CHOP Primary Care, South Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Beverly Hills, CA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Burbank, CA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Jacksonville, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Miami, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
North Miami, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Orlando, FL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Smyrna, GA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Rockville, MD
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
New York, NY
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Philadelphia, PA
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
Lake Jackson, TX
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated:  10/24/2016
GSK Investigational Site
mi
from
La Plata/Buenos Aires,
A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects With Social Anxiety Disorder
Status: Enrolling
Updated: 10/24/2016
GSK Investigational Site
mi
from
La Plata/Buenos Aires,
Click here to add this to my saved trials